Form 4 for PG Procter & Gamble
Accepted 2025-10-02 00:00:00 ET · period of report 2025-10-01 · accession 0000080424-25-000200 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-10-02 | 2025-10-01 | PG | Schulten Andre | CFO | A - Grant | $0.00 | +5,602 | 58.2K | +11% | $0 |
| D | 2025-10-02 | 2025-10-01 | PG | Schulten Andre | CFO | A - Grant | $0.00 | +77.6K | 77.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-01 | A | A | 5,602 | $0.00 | 58,244.03 | D | — | — | (F1) Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. |
| 2 | Derivative | Stock Option (Right to Buy) | 2025-10-01 | A | A | 77,648 | $0.00 | 77,648 | D | $153.18 · 2028-09-29 to 2035-10-01 | 77,648 Common Stock |